Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Cancers ‘change spots’ to avoid immunotherapy – Science Daily
  • Cancers “change spots” to dodge immunotherapy: study – PanARMENIAN.Net
    Cancers “change spots” to dodge immunotherapy: study – PanARMENIAN.Net
  • Cancers ‘change spots’ to avoid immunotherapy – EurekAlert
    Cancers ‘change spots’ to avoid immunotherapy – EurekAlert
  • Immunotherapy’s believers and skeptics: A review of Charles Graeber – The Christian Century
    Immunotherapy’s believers and skeptics: A review of Charles Graeber – The Christian Century
  • Cancer Immunotherapy Market to attain a value of US$124.88 billion by 2024 – TMR – GlobeNewswire
    Cancer Immunotherapy Market to attain a value of US$124.88 billion by 2024 – TMR – GlobeNewswire
  • Cancers ‘change spots’ to avoid immunotherapy – Medical Xpress
    Cancers ‘change spots’ to avoid immunotherapy – Medical Xpress
  • Cancers ‘change spots’ to avoid immunotherapy – EurekAlert
    Cancers ‘change spots’ to avoid immunotherapy – EurekAlert
  • Figlin Highlights Immunotherapy Developments in RCC – OncLive
    Figlin Highlights Immunotherapy Developments in RCC – OncLive
  • Cancer Immunotherapy Market to attain a value of US$124.88 billion by 2024 – TMR – GlobeNewswire
    Cancer Immunotherapy Market to attain a value of US$124.88 billion by 2024 – TMR – GlobeNewswire
  • Mok Provides Pembrolizumab Update, Next Steps With Immunotherapy in NSCLC – OncLive
    Mok Provides Pembrolizumab Update, Next Steps With Immunotherapy in NSCLC – OncLive
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com